Adenosine uptake sites have been characterized and localized in guinea pig and pointer dog brain by in vitro autoradiography, using as probes 3H-nitrobenzylthioinosine (3H-NBI) and the recently available . In guinea pig brain and, to a lesser extent, in pointer dog brain, 3H-DPR was found to label more high-affinity binding sites than 3H-NBI and NBI inhibited 3H-DPR binding having pseudoHill coefficients smaller than 0.5. 3H-DPR and 3H-NBI labeled brain structures with different intensities in guinea pig brain, as was revealed by quantitative analysis. While the intensity of 3H-DPR binding varied about 4-fold in neuron-containing structures, 8-fold differences were observed for 3H-NBI binding with phylo-and ontogenetically older brain areas such as hypothalamus and various brain stem structures showing relatively higher densities. These findings raise the interesting possibility of adenosine uptake site heterogeneity (NBI-sensitive and insensitive) in guinea pig brain, complementing the well-established adenosine receptor heterogeneity (Al and A2). As adenosine's neurodepressant effects are believed to be mainly mediated by adenosine Al -receptors, these were localized using 3H-cyclohexyladenosine (3H-CHA) as a ligand probe. In guinea pig brain, the highest receptor densities were seen in hippocampus and claustrum, while only relatively low levels were found in hypothalamus and various brain stem structures. As was previously described for rat brain, major discrepancies in the regional distribution of adenosine Al-receptors and adenosine uptake sites, as labeled by 3H-NBI, were seen in guinea pig brain. These discrepancies were only partly abolished (e.g., in cerebellum) by the use of 3H-DPR as an additional ligand probe for adenosine uptake sites. Adenosine uptake site heterogeneity, therefore, probably does not explain the previously described discrepancies in rodent brain between the distribution of adenosine Al -receptors and uptake sites. Because of the low affinity of 3H-DPR for adenosine uptake sites in rat and mouse brain, these species Received June 3, 1987; revised Oct. 13, 1987; accepted Nov. 27, 1987. J.D. is the recipient of a scholarship from Deutsche Forschungsgemeinschaft (DE-357/1-I).
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We are grateful to J. Unnerstall and T. Insel for providing the )H-microscales and to Miss T. In recent years, adenosine has been widely accepted as an important neuromodulator (for review, see Dunwiddie, 1985) . Its CNS depressant effects are believed to be mediated mainly by one (Al) of 2 ectocellular receptors (Al and A2) coupled to adenylate cyclase systems (van Calker et al., 1979; Londos et al., 1980) . Using adenylate cyclase assays, a different pharmacology and localization in brain for these 2 receptors has been demonstrated (Ebersolt et al., 1983; Wojcik and Neff, 1983) . On the basis of these adenylate cyclase studies, specific ligands for the adenosine A 1 -receptor-3H-cyclohexyladenosine (3H-CHA) (Bruns et al., 1980) 3H-phenylisopropyladenosine (3H-PIA) (Schwabe and Trost, 1980) , and, with some restrictions for the adenosine A2-receptor, 3H-ethylcarboxamidoadenosine (3H-NECA) (Yeung and Green, 1984) -have been developed and used for anatomical studies. Adenosine Al-receptors represent the majority of adenosine receptors in areas like cerebellum, superior colliculus, and the CA 1 region of hippocampus, while A2-receptors dominate in the olfactory tubercle, caudate putamen, and the mossy fibers of hippocampus (Lewis et al., 198 1; Goodman and Snyder, 1982; Lee and Reddington, 1986) . Extracellular concentrations of adenosine are regulated by the rapid transport of adenosine into cells, where it is metabolized either by adenosine kinase or deaminase (for review, see Pate1 et al., 1984) . This transport has been very extensively characterized in mammalian erythrocytes and tumor cell lines, and the existence of nitrobenzylthioinosine (NBI)-sensitive and insensitive transport has been described (Cass and Paterson, 1972; Kolossa and Pfleger 1975; Paterson et al., 1980; Belt, 1983; Plagemann and Wohlhueter, 1984) . On the other hand, only a few reports have appeared investigating this transport or uptake in mammalian brain (Huang and Daly, 1974; Bender et al., 1980; Barberis et al., 198 1) . The existence of rapid, high-affinity uptake in rat brain has been reported (Bender et al., 1980) , but no extensive characterization has been undertaken. NBI (['"Cl and [3H] ), one of a number of transport inhibitors, was, until recently, the only ligand probe for adenosine uptake sites (Pickard et al., 1973; Jarvis and Young, 1980; Marangos et al., 1982; Hammond and Clanachan, 1984) . It labeled, however, only a relatively low number of adenosine uptake sites and, in several rat brain areas, especially in cerebellum and hippocampus with high adenosine receptor density, only few adenosine uptake sites could be visualized (Geiger and Nagy, 1984; Bisserbe et al., 1985) , raising doubts about the capability of 3H-NBI to label all adenosine uptake sites. Similarly, direct measurement of adenosine uptake into guinea pig (and rat) brain slices or synaptosomes (Huang and Daly, 1974; Bender et al., 198 1; Phillis and Wu, 1983; Davies and Hambley, 1986; Morgan and Marangos, 1987) and studies of the enhancement of adenosine's effect on CAMP production (Huang and Daly, 1974) and EPSPs (Sanderson and Scholfield, 1986) by adenosine transport inhibitors indicate that, in guinea pig (and probably also in rat) brain, NBI in submicromolar concentrations inhibits only about half of the adenosine uptake inhibited by dipyridamole (DPR), another potent transport inhibitor.
Recently, 3H-DPR has been available as a ligand probe Bisserbe et al., 1986) . While no high-affinity 3H-DPR binding sites can be detected in membranes prepared from rat brain, 3H-DPR labels about 3 times more adenosine uptake sites than does 3H-NBI in guinea pig membranes, and NBI inhibits less than 50% of 3H-DPR binding in the nanomolar concentration range, suggesting heterogeneity of adenosine uptake sites in guinea pig brain (Marangos and Decker& 1987) .
Adenosine uptake site heterogeneity could obviously be the reason for the reported mismatches between uptake sites and adenosine A 1 -receptors in rat brain. As no high-affinity )H-DPR binding sites had been detected in rat brain, we decided to examine this possibility in 3 other species: mouse, guinea pig, and-as an example of a nonrodent mammal-pointer dog. We investigated the biochemical characteristics of 3H-DPR binding in brain slices of these 3 species and compared them in the 2 latter ones with the characteristics of 3H-NBI binding. In autoradiographic studies in guinea pig and pointer dog brain, we visualized the regional distribution of adenosine uptake sites labeled by these 2 probes as compared to adenosine Al-receptors labeled by 3H-CHA, and quantitatively analyzed the relative density of these binding sites in guinea pig brain.
Materials and Methods
In general, the procedure described by Herkenham and Pert (1982) was applied. Ten male NIH multipurpose guinea pigs (250-350 gm) and 6 male NIH Albino mice (about 30 gm) were decapitated. Four pointer dogs were anesthetized by pentobarbital(25 mg/kg) and kept in a respirator; their brain was surgically exposed, and the dogs then killed by an additional injection of pentobarbital (40 mg/kg) and KC1 (2 mEq/kg). The brains were immediately removed, frozen-in isopentane (-5O"C), and keot at -70°C until further use. For cuttinh, the brains were fixed onto a-brass microtome chuck with embedding&sue (Ml embedding matrix; Lipshaw, Detroit, MI). Twenty-micron sections were cut at -14°C in a Bright-Hacker cryostat, thaw-mounted on gelatin-coated glass slides (Kimble, Toledo, OH), and stored at -70°C until they were used in biochemical or autoradiographic experiments.
Biochemical experiments. Slide-mounted brain sections were incubated for 20 (guinea pig) or 30 (pointer dog and mouse) min in 50 mM Tris-HCl buffer, pH 7.4, at room temperature (22°C) with various concentrations of 'H-DPR (110 Ci/mmol; Moravek Biochemicals, Brea, CA). Nonspecific binding was defined in the presence of 50 MM DPR (Sigma, St. Louis, MO) and represented 35% (guinea pig), 20% (pointer dog), or 50% (mouse) of total binding at K,/2 concentrations. After the incubation, the slices were rinsed twice for 15 set (guinea pig), twice for 2 min (pointer dog), or twice for 4 min (mouse) in ice-cold incubation buffer. Similarly, brain slices (guinea pig and pointer dog) were incubated for 30 min in 50 mM Tris-HCl buffer, pH 7.4, at room temperature (22"(Z), with various concentrations of 3H-NBI (37 Ci/mmol; Moravek, Brea, CA). Nonspecific binding was defined in the presence of 5 pM NBI (Calbiochem, La Jolla, CA) and represented 25% (guinea pig) or 35% (pointer dog) of total binding at about K,/2 concentrations. After the incubation, the slices were rinsed twice for 1 min (guinea pig) or twice for 4 min (pointer dog) in ice-cold incubation buffer. Brain slices were also incubated for 60 min (guinea pig) or 90 min (pointer dog) in 50 mM Tris-HCl buffer, pH 7.4, containing 1.4 IU adenosine deaminase (from calf intestinal mucosa;.Sigma), at room temperature (22"C), with various concentrations of 3H-CHA (25 Ci/mmol; NEN-DuPont, Boston, MA). Nonspecific binding was defined in the presence of 20 PM CHA (Calbiochem) and represented 25% (guinea pig and pointer dog) of total binding at K,/2 concentrations. After the incubation, the slices were rinsed in ice-cold incubation buffer twice for 15 set (guinea pig) or twice for 2 min (pointer dog). In careful preliminary experiments, the respective incubation and rinsing times had been found to be the shortest to achieve saturation of binding and the optimal nonspecific : total binding ratio without loss of specific binding. After rinsing, the slices were wiped off the slides with Whatman GF/B filters, put in scintillation vials with 10 ml Beckman Ready-Solv, and counted at 40% efficiency in a Beckman LS 5800 scintillation spectrophotometer. To determine the protein content, adjacent slide-mounted sections were dried at room temperature overnight, then scraped off the slides and suspended in an aliquot of 50 mM Tris-HCl buffer, pH 7.4, by sonification. Protein was measured using the Biorad reagent (Bradford, 1976) .
Autoradiographic experiments. Adjacent slide-mounted sections of 3 guinea pig and 2 pointer dog brains were incubated with 3.5 nM (guinea pig ) or 2.5 nM (pointer dog) 3H-DPR, 0.6 nM (guinea pig) or 0.4 nM (pointer dog) 3HINBI, and 3.5 nM (guinea pig) or 5 nM (pointer dog) 3H-CHA under the respective conditions described above. Nonspecific binding under these conditions was quite homogeneous among gray matter structures and represented the above-mentioned fractions oftotal binding. Following the incubation and rinses, the slides were put on racks, dried under a stream of cold, filtered air, and placed in apposition to LKB ultrofilm, as first described by Penney et al. (1981) . After 2-4 (3H-DPR) or 4-8 (SH-NBI and 'H-CHA) weeks of exposure, the films were developed in Kodak D-19 (4 min at 22"(Z), fixed in Kodak Rapid Fixer (3 min), then rinsed for 30 min under running tap water, cleaned with deionized water, and dried. The autoradmgrams were screened and optical density measurements were performed using the computer image-processing system described by Gochee et al. (1980) . Optical density values were transformed into fmoVmg of dry tissue with Amersham 'H-microscale standards. Identifications of the brain microregions were made with aid of adjacent thionin-stained sections, using as references the atlases of Paxinos and Watson (1982) Luparello (1967), and Singer (1962.) Results Biochemical properties of 3H-DPR, 'H-NBI, and 'H-CHA binding to brain slices The affinity of 3H-DPR binding varied widely from species to species. Employing an isotopic dilution (11 Ci/mmol) and investigating a concentration range from 2 to 250 nM (n = 6), we could only obtain approximate estimates of the kinetic parameters (& between 90 and 150 nM) in mouse forebrain. This and the high nonspecific binding prevented us from undertaking a thorough investigation of this binding site. However, )H-DPR bound with sufficiently high affinity to guinea pig forebrain (Kd about 10 nM) and with even higher affinity to pointer dog prefrontal cortex slices (Kd about 1 nM) (Fig. 1) . In pharmacological experiments, DPR itself displaced 3H-DPR binding in guinea pig brain and pointer dog brain slices, with inhibition constants close to its own dissociation constants and pseudo-Hill coefficients of about 1 (1.2 and 0.8) (Fig. 2) . CHA was about lOOOfold less potent with inhibition constants in the high-nanomolar or low-micromolar range (Fig. 2) . NBI inhibited 3H-DPR binding, with K,s of about 20-(pointer dog) to 200-fold (guinea pig) Figure 2 . Displacement of 3H-DPR binding to adjacent prefrontal cortical slices in pointer dog brain by DPR (0), NBI (O), and CHA (0). A representative experiment is shown. The dashed line of the NBI displacement curve indicates that the inhibition curve was fitted according to a 2-site model, but that a fit according to a cooperative model would have been similarly justified. The pseudo-Hill coefficient (n,) for the inhibition by NBI was 0.4, the inhibition constant (K,) was calculated as 4.5 nM, and as K, estimate for the high-affinity component, 0.2 nM was obtained. Inhibition constants (K,) for DPR and CHA were 0.6 and 340 nM respectively. Similar results were obtained with forebrain slices in guinea pig brain, e.g., for NBI, 0.3 (n,), 1500 nM (K,), and 0.7 nM (K, estimate of high-affinity component), for DPR, 7 nM (K,) , and for CHA, 5200 nM (K,) . These experiments were repeated at least 3 times, with very similar results. Five to 10 concentrations of inhibitor were applied and the concentration of 3H-DPR was 3.5 nM in guinea pig and 2.5 nM in pointer dog.
higher than its own dissociation constant (Fig. 2) ; pseudo-Hill coefficients were lower than 1 -about 0.5 (pointer dog) and 0.3 (guinea pig). K, estimates for the high-affinity component, from curves drawn though the experimental points according to a 2-site model, were very close to Kds of high-affinity 3H-NBI binding (Figs. 1, 2) . Accordingly, the number of binding sites with Kds about 0.5 nM labeled by )H-NBI was smaller than the number of high-affinity 3H-DPR binding sites (Fig. 1 ). 3H-CHA binding experiments demonstrated high-affinity binding, in the 2 investigated species, with very similar characteristics (Fig. 1) .
Localization of 'H-DPR, 3H-NBI, and 'H-CHA binding sites
The gross patterns of 3H-DPR and 3H-NBI binding in guinea pig brain were rather similar (Figs. 3-6 ). However, the relative densities varied considerably from area to area (Table 1) . The highest 3H-DPR and 3H-NBI binding site densities were observed in non-neuronal structures. Both ligands labeled both the brain arteries (147 + 19 and 18 1 +-10 fmol/mg, respectively) and choroid plexus (111 f 10 and 134 -t 10 fmol/mg, respectively) very intensively. Very high 'H-DPR binding densities were observed in the ependymal cell lining of the lateral ventricles (195 +-20 fmol/mg), while relatively low 3H-NBI binding (57 f 2 fmol/mg) was found there.
Among neuron-containing structures, 7-fold differences in density were measured for 3H-NBI (e.g., area postrema: 155 -t 28 fmol/mg; globus pallidus: 23 f 2 fmol/mg), but less than 4-fold density differences for 3H-DPR (e.g., area postrema: 95 f 10 fmol/mg; globus pallidus: 29 f 2 fmol/mg). 3H-DPR binding was thus relatively homogeneous, e.g., superficial layers (l-4) of parietal cortex (SL-PC): 78 f 4 fmol/mg; medial preoptic area (MPO): 66 k 7 fmol/mg; molecular layer of cerebellum Other structures shown are caudate putamen (CP), pyriform cortex (PC) and supraoptic nucleus (SO). For better comparison, the images in Figures 3-6 were placed in apposition to the same film and exposed for 4 weeks. L&and concentrations were 3.5 nM for 3H-DPR and 'H-CHA and 0.6 nM for )H-NBI.
(ML-C): 66 + 4 fmol/mg; inferior olivary complex (IOC): 64 +-4 fmol/mg. To obtain an impression of the relative densities f 4 fmol/mg. The corresponding 3H-NBI densities in these of the 2 binding sites in basal and cortical brain structures, the representative brain areas were, for SL-PC, 48 + 3 fmol/mg; ratios MPO:SL-PC and IOCML-C were calculated. While they MPO, 90 + 6 fmol/mg; ML-C, 37 + 3 fmol/mg; and IOC, 71
were close to 1 for 3H-DPR (MPO:SL-PC, 0.85; IOCML-C, l), fmol/mg; 5, 100-200 fmol/mg; and for )H-CHA: 1,0-10 fmol/mg; 2, 40-80 fmol/mg; 3, SO-120 fmol/mg; 4, 120-160 fmol/mn; 5. 160-240 fmol/ mg; +/-indicateif the value is in the-upper/lower half of the adove ranges. The SEM of gray matter structures (6-30 measurements/structure from at least 2 different brains) were below 25%. N.D., not detected.
they approached values of about 2 for 3H-NBI (MPO:SL-C, 1.9; IOC:ML-C, 1.9).
3H-CHA binding sites in guinea pig brain were found in neuron-containing brain structures (Fig. 3-6 ). The relative densities in various brain structures differed widely from those obtained for 3H-DPR and even more so from those measured for 3H-NBI.
No specific 'H-CHA binding could be detected in non-neuronal structures such as brain arteries or choroid plexus, and only very low specific binding, not much different from that observed in some white matter structures, was seen in the ependymal cell lining of the lateral ventricles (40 f 6 fmol/mg).
The highest 3H-CHA binding densities were thus observed in neuron-containing structures (hippocampus and claustrum), with a 20-fold range in density (e.g., stratum radiatum: 193 + 2 fmol/ mg; and nucleus vestibularis medialis: 10 -t 2 fmol/mg). 3H-CHA binding was thus the most heterogeneous, e.g., SL-PC: 13 1 + 11 fmol/mg; MPO: 49 + 8 fmol/mg; ML-C: 89 f 10 fmol/mg; and IOC: 25 f 2 fmol/mg; and relatively more binding was seen in cortical than in basal brain structures (MPO:SL-C, 0.4; IOC:ML-C, 0.3).
In pointer dog, binding sites for 3H-CHA, 3H-DPR, and )H-NBI were investigated in neuron-containing brain structures (Figs. 7, 8 ). Similar patterns of uptake sites and adenosine Alreceptors were observed in cerebellum (high in molecular layer and low in granular cell layer) and, as opposed to guinea pig brain, also in hippocampus (relatively high uptake and receptor density in Ammon's horn and dentate gyrus). 
Discussion
In guinea pig brain homogenates, 3H-DPR binding has been pharmacologically characterized as binding to adenosine uptake sites, with adenosine transport inhibitors such as DPR, Hexobendine, and Dilazep demonstrating nanomolar, and adenosine receptor ligands like CHA and 1,3-diethylphenylxanthine showing micromolar potencies in displacing 3H-DPR binding (Marangos and Decker& 1987) . In good agreement with these membrane binding data are our findings in guinea pig forebrain and pointer dog prefrontal cortex slices that DPR itself inhibits 3H-DPR binding, with inhibition constants in the nanomolar range, and of CHA, with inhibition constants in the micromolar range.
Further evidence that 3H-DPR in fact binds to adenosine uptake sites is the observed species differences. The low-affinity binding of 3H-DPR in rat (Marangos and Decker?, 1987) and mouse brain, and the high-affinity binding in brains of guinea pig and pointer dog correspond well to the potencies of DPR in displacing 3H-NBI binding in these animals (Hammond and Clanachan, 1985; Verma and Marangos, 1985) . Also in good agreement with membrane binding data (Marangos and Decker& 1987) is the finding that NBI inhibits 3H-DPR binding in a biphasic manner. In guinea pig, micromolar concentrations are necessary to displace more than 40% of 3H-DPR binding. A high-and low-affinity component of this inhibition can be differentiated and the estimated inhibition constant of the high-affinity component (about 0.5 nM) was similar to the dissociation constant of . This indicates that 3H-NBI binding represents the subpopulation of 3H-DPR binding sites that is inhibited by NBI with subnanomolar affinity. NBI has been shown by several groups to inhibit adenosine uptake in guinea pig brain by less than 50%, while DPR inhibits practically all of it (Huang and Daly, 1974; Phillis and Wu, 1983; Davies and Hambley, 1986; Morgan and Marangos, 1987) . The good correlation between these functional data and the binding data obtained in brain membranes and brain slices suggests the use of 3H-NBI as a ligand probe for NBI-sensitive, and 'H-DPR as a ligand probe for NBI-sensitive, as well as NBI-insensitive, uptake sites in guinea pig brain.
The quantitative autoradiographic studies in guinea pig brain indicate that NBI-sensitive adenosine uptake sites, as labeled by 3H-NBI represent a varying fraction of the population of adenosine uptake sites labeled by 3H-DPR. In non-neuronal structures, numerous NBI-sensitive uptake sites seem to be present in arteries and choroid plexus, but only relatively few in the ependymal cells lining the ventricles. In neuron-containing brain regions, their density seems to be relatively higher in basal brain areas, such as hypothalamic structures and certain brain stem nuclei, than in cortical areas, such as the superficial layers of cerebral cortex and molecular and Purkinje cell layer of cerebellum, and also some hippocampal layers. This distribution is in good agreement with the previously described localization of 3H-NBI binding sites in autoradiographic studies in rat brain (Geiger and Nagy, 1984; Bisserbe et al., 1985) and in membrane binding studies in guinea pig and pig brain (Hammond and Clanachan, 1983; Kalaria and Harik, 1986a) . On the other hand, this would suggest that NBI-insensitive uptake sites are relatively more numerous in these cortical brain regions, which are ontologically and phylogenetically younger. This distribution pattern complements the above finding that 3H-DPR is a better ligand probe for adenosine uptake sites in man (unpublished observations), dog, and guinea pig than in mouse or rat. This The distributions of 'H-DPR and 3H-CHA binding sites are thus quite interpretation of our data thus would predict a higher ratio of NBI-sensitive adenosine uptake in guinea pig hypothalamus than in cerebellum, and a greater potency of dipyridamole in inhibiting adenosine uptake in man, dog, and guinea pig than in mouse or rat brain. In fact, DPR has already been demonstrated to be more potent in guinea pig than in rat in in vivo studies (Stafford, 1966) and in adenosine uptake studies in erythrocytes (Kolossa and Pfleger, 1975 ) and brain (Davies and Hambley, 1983; Morgan and Marangos, 1987) .
Although our studies strongly suggest the heterogeneity of adenosine uptake sites in guinea pig brain, they do not permit any conclusions to be made concerning its molecular basis, e.g., 2 conformational states (Hammond and Clanachan, 19854 or a functional dimer (Jarvis and Young, 1981 ) with 2 different subunits or 2 completely separate uptake sites; nor do they allow any conclusions on the cellular (neuronal or glial) or subcellular (plasma, mitochondrial, or nuclear membrane) localization of the 2 suggested subtypes.
A previous autoradiographic study in rat brain (Bisserbe et al., 1985) with 3H-NBI as a ligand probe for adenosine uptake sites demonstrated low densities of adenosine uptake sites, as opposed to high densities of adenosine Al-receptors in areas highly enriched in synapses, such as various hippocampal layers and the molecular layer of cerebellum. An obvious explanation for this gross mismatch could be the existence of adenosine uptake site subtypes. The existence of adenosine receptor subtypes, for instance, probably explains one gross mismatch in the present study: In guinea pig brain, adenosine Al -receptors could not be detected at all in non-neuronal structures such as arteries and choroid plexus, with high adenosine uptake site densities, in good agreement with a membrane binding study describing adenosine A2-receptors in these structures in pig (Kalaria and Harik, 1986b) . As in rat brain, major pattern differences were observed between adenosine A 1 -receptors and uptake sites as labeled by 3H-NBI in guinea pig brain. In fact, their density patterns were exactly opposite: high 3H-CHA and low 3H-NBI binding in cortical structures, and high 3H-NBI and low 3H-CHA binding densities in basal brain structures. This confirms previous membrane binding studies examining up to 8 regions (Murray and Cheney, 1982; Hammond and Clanachan, 1983) . A better correlation could be observed between 3H-CHA and 3H-DPR binding sites, especially in cerebellum with a very similar pattern. In hippocampus, moderate 3H-DPR, in addition to very high 3H-CHA binding, was found, but with an inverse pattern: very high 3H-CHA binding density in various CA1 layers and the hilus, but only moderate binding in the molecular layer of the dentate gyrus, as opposed to relatively high 3H-DPR binding in the molecular layer and relatively lower density in layers of CA1 and the hilus. Thus, even with the use of 3H-DPR as an additional ligand probe for adenosine uptake sites, discrepancies in receptor and uptake site distribution remained. Adenosine uptake site heterogeneity (as well as adenosine receptor heterogeneity;
see Lee and Reddington, 1986 ) therefore probably does not explain the majority of the previously described discrepancies.
similar in the cerebellum, with high binding in molecular (ML) and Purkinje cell (PL) layers and low densities in the granular cell layer (GL) and lateral cerebellar nucleus (Lc). Other structures shown are the rostral part of the nucleus tractus solitarii (NTS) and inferior olivary complex (IO). , and 'H-CHA (bottom) binding sites in adjacent coronal sections in the plane of the hippocampus of a pointer dog brain. The distribution of all 3 binding sites is very similar to their distribution in guinea pig brain. The only remarkable difference is their practically identical localization in layers of Ammon's horn (H), and dentate gyrus (DC). Other structures shown are parietal cortex (CC), superior colliculus (superficial gray, SG), central gray (CG), medial geniculate body (GB), and substantia nigra (,!W). Sections labeled with 3H-NBI and 'H-CHA were exposed for 8 weeks together with the corresponding sections in Figure 8 because of the relative low binding densities and the low specific activity of the radiolabels as contrasted to the 3H-DPR sections, which were again exposed for 4 weeks. Ligand concentrations were 2.5 nM for )H-DPR, 0.4 11~ for 3H-NBI, and 5 nM for 'H-CHA. Adenosine uptake site heterogeneity, as proposed in guinea pig brain, may thus serve as an explanation for some, but not all, of the distribution mismatches previously observed in rat brain between adenosine A 1 -receptors and adenosine uptake sites as labeled by 3H-NBI. As in guinea pig, NBI has been shown to inhibit less than 50% of adenosine uptake in rat brain synaptosomes in submicromolar concentrations (Bender et al., 198 l) , and a recent study of adenosine uptake into rat brain synaptoneurosomes demonstrates a biphasic inhibition of this uptake by NBI (Morgan and Marangos, 1987) . Owing to the low affinity of DPR for adenosine uptake sites in rat and mouse brain, however, it cannot be used as a high-affinity ligand probe in these species, as in guinea pig, and the development of new, high-affinity ligand probes for NBI-insensitive uptake sites in these species is required to probe the possibility of adenosine uptake site heterogeneity. In dog brain, no functional data are available at the present time. The inhibition of 3H-DPR binding to pointer dog prefrontal cortex slices by NBI was not as biphasic as in guinea pig, and a possible lower-affinity 3H-NBI binding site was not excluded under our experimental conditions because of the limitations of the method. In the autoradiographic experiments, a similar distribution pattern was seen for both adenosine uptake site probes in hippocampus and cerebellum, which could well be explained by the existence of a lower-affinity 3H-NBI binding site. Also, as opposed to the case of guinea pig and rat, the distribution pattern of 3H-CHA binding was very similar to that of both uptake site probes, not only in cerebellum, but also hippocampus, which could be partly due to the different cytoarchitecture of dog and rodent hippocampus. The observed species differences clearly caution against drawing any conclusions regarding the adenosine uptake site and its relationship to adenosine Al-receptors from one species to the other. This is in contrast to adenosine A 1 -receptors themselves, which seem to be well conserved between species (at least among rodents), but similar to Snucleotidase, the distribution of which also varies from rodent to rodent (Lee et al., 1985) .
Among areas with both adenosine Al-receptor and uptake sites in guinea pig and pointer dog brain were many structures whose function was to receive and modulate sensory input, such as pyriform cortex, superior colliculus, cochlear nucleus, and nucleus spinalis nervi trigemini, and, on a higher level, the geniculate bodies, various nuclei of amygdala and thalamus, hippocampus, and finally cerebral cortex (sensory part) and cerebellar cortex. This suggests a role for adenosine in the regulation of sensory input, which, in protecting the brain from "overexcitation" in the context of Newby's concept of adenosine as a retaliatory metabolite (Newby, 1984) , may well be its main physiological role. The nature of this adenosinergic neuromodulation could be considerably influenced by the relative density of receptors (potential for neurodepression by adenosine) and uptake sites (capacity for uptake and inactivation of adenosine). The discrepancy between receptor and uptake site density in structures like hypothalamus, area postrema, and nucleus tract brain stem structures and higher binding density in the molecular layer (ML) than in the granular cell layer (CL). In contrast to the situation in guinea pig brain and similar to the situation in pointer dog forebrain (Fig. 7) both 'H-DPR and 3H-NBI binding show a similar-pattern to that of 'H-CHA and denser labeling in the cerebellum than in various brain stem structures, such as nucl&s tractus solitarii (NTS), nucleus nervi hypoglossi (NNZZ), and the inferior olivary complex (IO). tus solitarii, with high uptake site density, may thus find an explanation in the need to keep adenosine concentrations modulating vital autonomous and endocrine functions in these areas via relatively few receptors, independent from increases in plasma adenosine levels, while the moderate uptake site density in hippocampus may indicate a need for a relatively high extracellular adenosine concentration to modulate excitatory hippocampal neurons via an extraordinarily high number of receptors. Several enzymes involved in adenosine metabolism, such as S'nucleotidase (Scott, 1967) adenosine deaminase and S-adenosylhomocysteine hydrolase (Pate1 and Tudball, 1986) have been localized in brain with histochemical and immunocytochemical techniques, and have been suggested as markers for adenosinergic neurons. Parallels in the distribution of 3H-NBI binding sites and in the distribution of adenosine deaminase immunoreactivity in rat brain have been observed (Nagy et al., 1985) . Recently, the distribution of adenosine itself has been described in rat brain, using a polyclonal antibody (Braas et al., 1986) . It has been found colocalized with adenosine A 1 -receptors to retinal ganglion cells, and a good, but not complete, correlation with adenosine uptake sites as labeled by 3H-NBI has been reported (Braas et al., 1987) . The similarities and discrepancies in the distribution of adenosine uptake sites, as labeled by )H-NBI, and these various markers in rat brain with regard to potential implications for adenosinergic neuromodulation have been discussed (Braas et al., 1986) . However, owing to the different resolution limits, comparisons between studies employing radioligand probes and antibodies are rather difficult. Possibly only for this reason, the remarkable concentrations observed for adenosine in circumscript motor nuclei do not find any correspondence in observations from radioligand studies (exception: moderate adenosine uptake site density in nucleus nervi hypoglossi). The availability of 3H-DPR as ligand probe for NBI-insensitive adenosine uptake sites thus resolves only few of the observed discrepancies. The only area in which a similar distribution pattern for most of these putative markers for a postulated adenosinergic system has now been established is cerebellum: adenosine A 1 -receptors, adenosine itself, adenosine uptake sites (especially when labeled by 3H-DPR), S'nucleotidase, and, with some restrictions, also S'adenosylhomocysteine hydrolase have been described in descending density in the Purkinje cell layer, the molecular layer, and the granular cell layer of cerebellar cortex. Interpretation of the observed pattern similarities and discrepancies of these markers in relation to adenosine uptake sites with regard to potential implications for adenosinergic neuromodulation is necessarily even more complex than the interpretation of the distribution pattern of adenosine uptake sites and receptors, not just for the abovementioned technical reasons, but also because the enzymes concerned and adenosine itself are probably involved in a range of cell processes besides modulation of neurotransmission (see Braas et al., 1986) . Nevertheless, these markers, in addition to ligand probes for adenosine receptors and uptake sites, such as 3H-DPR, will probably prove to be useful tools in future studies defining the anatomical localization of adenosinergic neuromodulation in human brain (Fastbom et al., 1986; Braas et al., 1987) .
